Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Shinako Takada

Dr. Shinako Takada

Scientific Review Officer



Biography

Division:
Division of Physiological and Pathological Sciences – DPPS
Review Branch:
Disease Control and Applied Immunology – DCAI
Study Section:
Antiviral Drug Discovery and Molecular Pharmacology – DCAI (81)

Small Business: Microbial Diagnostics and Detection – DCAI (13)

Dr. Shinako Takada received her Ph.D. in basic medical science from the University of Tokyo in Japan, where she studied mechanisms of hepatitis B virus-induced hepatocarcinogenesis. Her post-doctoral research in the Department of Molecular and Cell Biology at the University of California, Berkeley, included studies on eukaryotic RNA polymerase I, II, and III based transcription. Before she joined NIH as a scientific review officer, she was a tenured associate professor in the Department of Biochemistry and Molecular Biology at the University of Texas M.D. Anderson Cancer Center, where her laboratory studied regulatory mechanisms of RNA Polymerase II transcription from non-canonical (TATA-less) promoters.

 

Last updated: 09/18/2025 05:01